STEVEN MADDEN, LTD.

SHOO

Held by 1 specialist biotech fund

Fund Holdings

AI Signal

**Signal Note - SHOO Position Initiation** Driehaus Capital's $35.7M entry into Steven Madden (SHOO), a footwear retailer, represents a notable portfolio shift rather than a biotech catalyst.

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 857,979Value: $35.7M

**Signal Note - SHOO Position Initiation** Driehaus Capital's $35.7M entry into Steven Madden (SHOO), a footwear retailer, represents a notable portfolio shift rather than a biotech catalyst. This appears inconsistent with the fund's stated growth/biotech focus and warrants clarification on investment thesis—whether this reflects a tactical value position, portfolio rebalancing, or data error in the filing.

More SHOO Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: